Skip to main content
. 2020 May 19;12:3579–3587. doi: 10.2147/CMAR.S243660

Figure 3.

Figure 3

Anlotinib reduces metastatic potential of KRAS mutant lung cancer cells. (A) Transwell detection of invasive ability with Anlotinib treatment. (B) The Wound healing analysis of migration ability after Anlotinib treatment. *P<0.05**P<0.01